Join us on 2/9 as clinical, regulatory and real-world evidence experts discuss the impact of decentralized trials on the evolution of drug dev in oncology.
Partners with Universities of Birmingham, Leeds and Edinburgh to create open-access facility to enhance SME and larger corporate partners’ product development
Will leverage Avidity's technology platform for the discovery, development and commercialization of potential new medicines in immunology and other indications